CSF-1R+ macrophages are related to immunosuppression and tumor progression, and the expression of CSF-1R in TAMs is associated with an unfavorable prognosis and resistance to tumor immunotherapy (Koh et al., 2014; Candido et al., 2018; Gyori et al., 2018). This evidence concerns the gene CSF1R and neoplasm.